Skip to content
Contactez-nous: (+33) 1 64 62 10 12
Home
Company
About us
Our history
A word from our CEO
Our management team
Board of directors
Know-how
Privacy policy
Theranostic
Therapeutic Drug Monitoring of Biologics – TRACKER
Therapeutic Drug Monitoring of Biologics
TDM of Biologics
When to perform TDM ?
Results interpretation
Therapeutic Thresholds
Tracker Publications
Guidelines
Frequently asked questions
TRACKER
LISA TRACKER
I-Tracker
i-Track 10
Immunotrol Tracker
Patient Stratification -PredictImmune
American Customers
Diagnostics
Autoimmunity
Reagents – Autoimmunity
Quality Control – Auto-Immunity
SARS-CoV 2 Serology Testing
Other fields
Instrumentation
Theralis
FIDIS™
Services
Technical Documentation Download Center
News
Press Releases
List of upcoming events
Congress calendar
Investors
Welcome Message
Financial News
Register to receive our latest news
Press Releases
Financial Reports
Financial presentations
Shareholder information
Stock information
Shareholding
Analyst coverage
Letters to shareholders
General meeting
Regulated information
Share capital and voting rights
Corporate governance & internal control
Statutory auditors fees
Description of the buyback program
Prospectus
Share buyback statement
Charters and code of ethics / Anti-corruption
Other regulated information
Governance
Board of directors
Statute and internal regulations
Quiet period policy and trading windows
Investor contacts and registration
Legal notice
Contacts
Menu
Close
Regulated information
Home
>
Investors
>
Regulated information
Home
Company
About us
Our history
A word from our CEO
Our management team
Board of directors
Know-how
Privacy policy
Theranostic
Therapeutic Drug Monitoring of Biologics – TRACKER
Therapeutic Drug Monitoring of Biologics
TDM of Biologics
When to perform TDM ?
Results interpretation
Therapeutic Thresholds
Tracker Publications
Guidelines
Frequently asked questions
TRACKER
LISA TRACKER
I-Tracker
i-Track 10
Immunotrol Tracker
Patient Stratification -PredictImmune
American Customers
Diagnostics
Autoimmunity
Reagents – Autoimmunity
Quality Control – Auto-Immunity
SARS-CoV 2 Serology Testing
Other fields
Instrumentation
Theralis
FIDIS™
Services
Technical Documentation Download Center
News
Press Releases
List of upcoming events
Congress calendar
Investors
Welcome Message
Financial News
Register to receive our latest news
Press Releases
Financial Reports
Financial presentations
Shareholder information
Stock information
Shareholding
Analyst coverage
Letters to shareholders
General meeting
Regulated information
Share capital and voting rights
Corporate governance & internal control
Statutory auditors fees
Description of the buyback program
Prospectus
Share buyback statement
Charters and code of ethics / Anti-corruption
Other regulated information
Governance
Board of directors
Statute and internal regulations
Quiet period policy and trading windows
Investor contacts and registration
Legal notice
Contacts
